{"id":"W2593028116","doi":"10.1182/blood.v120.21.4255.4255","title":"Cost-Effectiveness of Ruxolitinib Versus Best-Available Therapy for Medical Treatment of Myelofibrosis: Canadian Societal Perspective","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Reimbursement; Cohort; Internal medicine; Cost effectiveness; Health care","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003145869,0.0007437592,0.0009608014,0.001555454,0.001220369,0.00271246,0.001750748,0.001528181,0.004595968],"category_scores_gemma":[0.01220487,0.00047195,0.00169524,0.001891139,0.0007678757,0.0008112148,0.0007727068,0.001507025,0.0001515006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05913169,"about_ca_system_score_gemma":0.05440169,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9528334,"about_ca_topic_score_gemma":0.9391927,"domain_scores_codex":[0.9977928,0.001089163,0.00007054374,0.0001625135,0.0004819939,0.0004029734],"domain_scores_gemma":[0.9956269,0.002301374,0.0003553453,0.00008629869,0.001173785,0.0004562563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001888667,0.0002455749,0.04079988,0.0009137732,0.001452378,0.0006103085,0.0002792139,0.8462825,0.0005838471,0.04344185,0.01643817,0.04706389],"study_design_scores_gemma":[0.001052255,0.0006191399,0.03829464,0.0009009956,0.001705195,0.0003351502,0.001006363,0.9236466,0.0005451533,0.01373668,0.01790049,0.0002574579],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7440146,0.03894113,0.01703977,0.05342025,0.0004146215,0.0008350385,0.0276282,0.0001718736,0.1175345],"genre_scores_gemma":[0.9907104,0.003251323,0.002882007,0.0005531047,0.00003237177,0.00005421546,0.001342229,0.00001284521,0.001161388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05913169,"threshold_uncertainty_score":0.4290324,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08230238664045916,"score_gpt":0.3607288151993117,"score_spread":0.2784264285588525,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}